The program brought Tau Medical together with experts in U.S. regulatory strategy, reimbursement, commercialization, and market access as the company continues to advance its U.S. development strategy. KHIDI supports the global expansion of Korea’s healthcare industry, while the University of Utah’s Center for Medical Innovation provides expertise spanning medical device development, regulatory affairs, and commercialization.
During the workshop, the Tau Medical team met with CMI leaders and experts, as well as leaders from Utah’s broader MedTech, finance, and investment community.
- Mark PaulExecutive Director
- Spencer WalkerDirector of Regulatory Affairs
- Kolja KlugEngineer
- Amanda LeMattyProgram Manager
University of Utah Center for Medical Innovation
The workshop provided an opportunity to review Tau Medical’s U.S. strategy from multiple perspectives and to strengthen connections within the growing Utah and U.S. MedTech ecosystem. Tau Medical thanks KHIDI, the University of Utah Center for Medical Innovation, and the participating experts for their insights and support.